[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper does not explicitly state a specific disease mechanism for EGFR L858R but implies its relevance to cancer progression through EGFR's role in cell growth and proliferation.",
        "judgment": "Yes",
        "reasoning": "EGFR's function is generally linked to cancer. While not specifically defined, this establishes a link to a disease mechanism.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper reports on enzyme activity assays of EGFR kinase domain mutations. These assays are widely accepted to model the impact of mutations on kinase activity, which directly affects downstream signaling pathways in cancer.",
        "judgment": "Yes",
        "reasoning": "Enzyme activity assays are a standard method for assessing the impact of kinase mutations in cancer. They directly model disease mechanisms.",
        "next_step_or_outcome": "Proceed to Step 1 - Sub-step 3a"
      },
      {
        "step_name": "Step 1 - Sub-step 3a: Basic Controls and Replicates",
        "extracted_paper_info": "The paper does not explicitly mention 'normal' or 'wild-type' controls in the enzymatic assays and it is unclear whether multiple replicates were used.",
        "judgment": "No",
        "reasoning": "The lack of clear documentation on basic controls/replicates necessitates proceeding to sub-step 3b.",
        "next_step_or_outcome": "Proceed to Sub-step 3b"
      },
      {
        "step_name": "Sub-step 3b: Accepted/Validated Assay",
        "extracted_paper_info": "Enzyme activity assays are a widely accepted assay used in the field for evaluating kinase domain mutations.",
        "judgment": "Yes",
        "reasoning": "Given that enzyme activity assays are widely accepted within the field, this justifies assignment of supporting strength even without full controls/replicates.",
        "next_step_or_outcome": "Proceed to Step 1 - Sub-step 3c"
      },
      {
        "step_name": "Step 1 - Sub-step 3c: Variant Controls",
        "extracted_paper_info": "The paper did not explicitly use other pathogenic or benign variants as controls.",
        "judgment": "No",
        "reasoning": "The lack of variant controls requires Max PS3/BS3 supporting.",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "The paper does not explicitly describe statistical analysis to calculate OddsPath for EGFR L858R, so statistical analysis are not performed.",
        "judgment": "No",
        "reasoning": "Without statistical analysis it is unable to derive OddsPath values.",
        "next_step_or_outcome": "Proceed to Step 4 - Sub-step 4b"
      },
      {
        "step_name": "Step 4 - Sub-step 4b: No OddsPath Calculation",
        "extracted_paper_info": "The study did not explicitly state how many other pathogenic or benign variants were used to evaluate this mutation.",
        "judgment": "N/A",
        "reasoning": "Insufficient information to determine control number.",
        "next_step_or_outcome": "Final Assessment"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "Due to limited information about the use of specific controls and lack of OddsPath calculation, the data collected for this variant is assigned a PS3_supporting strength. The enzymatic assay reflects a general link to pathogenesis."
  }
]